Does LENALIDOMIDE Cause Basal cell carcinoma? 685 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 685 reports of Basal cell carcinoma have been filed in association with LENALIDOMIDE (LENALIDOMIDE). This represents 0.2% of all adverse event reports for LENALIDOMIDE.
685
Reports of Basal cell carcinoma with LENALIDOMIDE
0.2%
of all LENALIDOMIDE reports
9
Deaths
92
Hospitalizations
How Dangerous Is Basal cell carcinoma From LENALIDOMIDE?
Of the 685 reports, 9 (1.3%) resulted in death, 92 (13.4%) required hospitalization, and 25 (3.6%) were considered life-threatening.
Is Basal cell carcinoma Listed in the Official Label?
Yes, Basal cell carcinoma is listed as a known adverse reaction in the official FDA drug label for LENALIDOMIDE.
What Other Side Effects Does LENALIDOMIDE Cause?
Diarrhoea (27,576)
Fatigue (22,956)
Death (19,213)
Off label use (17,017)
Rash (15,794)
Pneumonia (14,807)
Plasma cell myeloma (14,191)
Neuropathy peripheral (10,215)
White blood cell count decreased (9,996)
Constipation (9,635)
What Other Drugs Cause Basal cell carcinoma?
ADALIMUMAB (1,547)
INFLIXIMAB (1,340)
METHOTREXATE (1,268)
RITUXIMAB (1,085)
ETANERCEPT (998)
ABATACEPT (852)
TOCILIZUMAB (761)
HYDROXYCHLOROQUINE (662)
LEFLUNOMIDE (657)
ALENDRONATE (610)
Which LENALIDOMIDE Alternatives Have Lower Basal cell carcinoma Risk?
LENALIDOMIDE vs LENIOLISIB
LENALIDOMIDE vs LENOGRASTIM
LENALIDOMIDE vs LENVATINIB
LENALIDOMIDE vs LEPONEX
LENALIDOMIDE vs LERCANIDIPINE